c-Kit-IN-5-1 structure
|
Common Name | c-Kit-IN-5-1 | ||
---|---|---|---|---|
CAS Number | 1003311-62-3 | Molecular Weight | 395.413 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 720.7±70.0 °C at 760 mmHg | |
Molecular Formula | C23H17N5O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 389.7±35.7 °C |
Use of c-Kit-IN-5-1c-Kit-IN-5 is potent inhibitor of c-Kit, with IC50s of 22 nM and 16 nM in kinase assay and cell assay, respectively. c-Kit-IN-5 shows more than 200-fold selectivity for c-Kit over KDR, p38, Lck, and Src. c-Kit-IN-5 also exhibits desirable pharmacokinetic properties[1]. |
Name | 3-(2-Amino-6-quinazolinyl)-4-methyl-1-[4-(1,3-oxazol-2-yl)phenyl]-2(1H)-pyridinone |
---|---|
Synonym | More Synonyms |
Description | c-Kit-IN-5 is potent inhibitor of c-Kit, with IC50s of 22 nM and 16 nM in kinase assay and cell assay, respectively. c-Kit-IN-5 shows more than 200-fold selectivity for c-Kit over KDR, p38, Lck, and Src. c-Kit-IN-5 also exhibits desirable pharmacokinetic properties[1]. |
---|---|
Related Catalog | |
In Vitro | c-Kit-IN-5 (compound 25) shows more than 200-fold selectivity against KDR, p38, Lck, and Src (IC50=>5.0, 40, 7.8 , and >5.0 μM, respectively)[1]. |
In Vivo | c-Kit-IN-5 (compound 25) (1 mg/kg; i.v.) exhibits CL (0.46 L/h/kg) and Vdss (1.59 L/kg) in rats[1]. c-Kit-IN-5 (10 mg/kg; p.o.) exhibits AUC0-t(9860 ng•h/mL) Cmax(1230 ng/mL), T1/2 (2.6 h), and F (39%) in rats[1]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 720.7±70.0 °C at 760 mmHg |
Molecular Formula | C23H17N5O2 |
Molecular Weight | 395.413 |
Flash Point | 389.7±35.7 °C |
Exact Mass | 395.138214 |
LogP | 2.78 |
Vapour Pressure | 0.0±2.3 mmHg at 25°C |
Index of Refraction | 1.709 |
Storage condition | -20°C |
Hazard Codes | Xn |
---|
2(1H)-Pyridinone, 3-(2-amino-6-quinazolinyl)-4-methyl-1-[4-(2-oxazolyl)phenyl]- |
3-(2-Amino-6-quinazolinyl)-4-methyl-1-[4-(1,3-oxazol-2-yl)phenyl]-2(1H)-pyridinone |
AMG-25 |